Daniel Vasella, chief executive and chairman Novartis
September 17, 2009Sales and Marketing Novartis, Vasella
FDA warns Bayer over German API facility
September 17, 2009Manufacturing and Production Bayer, FDA, reg
The US regulator has sent a warning letter to Bayer indicating it found "significant deviations from US current good manufacturing …
GPs gain QOF concessions in return for swine flu work
September 17, 2009NHS, qof
GPs are to administer swine flu jabs in the government’s forthcoming vaccination scheme in return for some administrative concessions.These include …
ABPI defends OLS Blueprint against member scepticism
September 17, 2009ABPI
Over half of ABPI members believe the government's latest efforts to help the life sciences sector will not make a …
Merck’s osteoporosis candidate shows some promise in trials
September 16, 2009Research and Development, Sales and Marketing Cancer, Merck
Merck & Co's investigational cathepsin K inhibitor odanacatib has shown some promise in a trial to treat osteoporosis in postmenopausal …
Conservatives leading on ‘industrial policy’ say CBI
September 16, 2009Research and Development ABPI, hc, reform
A change of government would benefit UK pharma, according to the Confederation of British Industry, which says the industry might …
Puerto Rican ops hold back Patheon
September 16, 2009Manufacturing and Production Patheon
Canadian contract manufacturer Patheon has reported ‘disappointing’ third-quarter results, with a resurgence of problems at its Puerto Rican operations contributing …
Pharma calls for action to boost medicines research
September 16, 2009Sales and Marketing ABPI
A better environment for the UK life sciences sector is vital for the country's economic recovery, according to the Association …
GSK encouraged by first H1N1 vaccines results
September 15, 2009Sales and Marketing GSK, h1n1
Results from the first trial of GlaxoSmithKline's new pandemic swine flu vaccine have been revealed. A German study of 130 …
Medea Communications launches
September 15, 2009Medical Communications Medea
Medea Communications, a new medical education agency, was launched this week by former directors from PR agency Fleishman-Hillard.Set up by …
Solvay clears hurdle in cell-based flu vaccine supply
September 15, 2009Manufacturing and Production Solvay
A manufacturing facility in the Netherlands operated by Solvay Biologicals has passed an inspection by Dutch authorities and is ready …
Manufacturing facility news in brief
September 14, 2009Manufacturing and Production BMS
Pharmafocus' round-up of manufacturing facility news includes plant disposals by BMS and Sanofi-Aventis, a new build for device company Haselmeier …
Lonza breaks ground on new cell therapy facility
September 14, 2009Manufacturing and Production Lonza
Swiss contract manufacturer Lonza has broken ground a new manufacturing unit for cell-based therapies, located at the Tuas Biomedical Park …
Lilly sponsors chronic pain website
September 14, 2009Medical Communications patients
Lilly is sponsoring a new website looking at the problems of the widespread chronic pain condition fibromyalgia. KnowFibro.com has been …
Health 4 Brands launched in the UK
September 11, 2009Medical Communications Euro RSCG, advertising
Euro RSCG Life has launched Health 4 Brands as a second health agency in the UK. Health 4 Brands (H4B) …
Contract manufacturing news in brief
September 11, 2009Manufacturing and Production
Newsflow in the contract manufacturing sector is picking up again as the summer draws to a close, with new agreements …
Biotech suffers as recession hits
September 11, 2009Medical Communications biotech, intercytex
The fears of many biotech leaders are being realised, as a string of small-scale companies face liquidation at the hands …
Roche divests protein expression portfolio
September 10, 2009Research and Development Roche, genomics
Roche has sold its cell-free protein expression kits business for an undisclosed sum.Berlin-based company RiNA will take control of the …
Cipla plans push into biosimilars
September 10, 2009Sales and Marketing biosimilars, generics
Mumbai-based generics manufacturer Cipla is to begin making biosimilars, generic substitutable versions of branded biologic drugs. It plans to do …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
